15132966

Source:http://linkedlifedata.com/resource/pubmed/id/15132966

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0001688, umls-concept:C0003448, umls-concept:C0087111, umls-concept:C0879626
pubmed:issue	10
pubmed:dateCreated	2004-5-10
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/15132966-12569078
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9421642
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antitubercular Agents, http://linkedlifedata.com/resource/pubmed/chemical/Pyrazinamide
pubmed:status	MEDLINE
pubmed:month	May
pubmed:issn	1073-449X
pubmed:author	pubmed-author:ChanChi KuenCK, pubmed-author:LeungChi ChiuCC, pubmed-author:YewWing WaiWW
pubmed:issnType	Print
pubmed:day	15
pubmed:volume	169
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1168-9; author reply 1169
pubmed:dateRevised	2004-11-17
pubmed:meshHeading	pubmed-meshheading:15132966-Antitubercular Agents, pubmed-meshheading:15132966-Dose-Response Relationship, Drug, pubmed-meshheading:15132966-Humans, pubmed-meshheading:15132966-Maximum Tolerated Dose, pubmed-meshheading:15132966-Proportional Hazards Models, pubmed-meshheading:15132966-Pyrazinamide, pubmed-meshheading:15132966-Risk Assessment, pubmed-meshheading:15132966-Tuberculosis, Pulmonary
pubmed:year	2004
pubmed:articleTitle	Side effects of antituberculosis therapy.
pubmed:publicationType	Letter, Comment